Most Cited
| Year | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| No. of Published Articles | 240 | 480 | 760 | 633 | 702 | 655 | 622 | 661 | 702 | 5455 |
| Citations | 2027 | 3470 | 4084 | 2232 | 1602 | 1043 | 678 | 392 | 51 | 15579 |
| Article published in 2010 and 2011: 720, Citation in 2012 to articles Published in 2010 and 2011- 5497 Impact Factor (2012): 5497/720 = 7.63 (On the basis of citations) Article published in 2011 and 2012: 1240, Citation in 2013 to articles Published in 2011 and 2012- 7554 Impact Factor (2013): 7554/1240 = 6.09 (On the basis of citations) Article published in 2012 and 2013: 1393, Citation in 2014 to articles Published in 2012 and 2013- 6316 Impact Factor (2014): 6316/1393 = 4.53 (On the basis of citations) Article published in 2013 and 2014: 1335, Citation in 2015 to articles Published in 2013 and 2014- 3834 Impact Factor (2015): 3834/1335 = 2.87 (On the basis of citations) Article published in 2014 and 2015: 1357, Citation in 2016 to articles Published in 2014 and 2015- 2645 Impact Factor (2016): 2645/1357 = 1.94 (On the basis of citations) Article published in 2015 and 2016: 1277, Citation in 2017 to articles Published in 2015 and 2016- 1721 Impact Factor (2017): 1721/1277 = 1.34 (On the basis of citations) Article published in 2016 and 2017: 1283, Citation in 2018 to articles Published in 2016 and 2017- 1070 Impact Factor (2018): 1070/1283 = 0.83 (On the basis of citations) Five Year Projected Impact Factor: 5947/3273 = 1.81 |
||||||||||
AN APPROACH TO INCREASE THE SOLUBILITY OF RIFAMPICIN BY SOLID DISPERSION TECHNIQUE
Solubility is one of the important parameter to achieve desired concentration of drug in systemic circulation for pharmacological response to be shown. Poorly water soluble drugs often require high doses in order to reach therapeutic plasma concentrations after oral administration. Any drug to be absorbed must be present in the form of an aqueous solution at the site of absorption. Most of the dru...
1991
524
β-CYFLUTHRIN-INDUCED IMPAIRMENT IN NEUROTRANSMITTERS, TESTICULAR FUNCTION AND GENE EXPERISSIONS OF MALE RATS: THE PROTECTIVE ROLE OF OMEGA-3
The present study was designed to evaluate the protective effect of omega-3 against β-cyfluthrin (β-cyf)-induced neurotransmitters’ impairment, oxidative damage, testicular toxicity and genotoxicity. Adult male Wistar rats were divided equally into four groups: Group (I): Control, Group (II): β-cyf (5 mg/kg body weight/day), Group (III): omega-3 (400 mg/kg body weight/da y) + β-cyf (5 mg/kg ...
3484
730
EVALUATION OF CRITICAL CONSUMABLES IN CLEANROOM OF ASEPTIC AREA
Sterility is the complete absence of any viable microorganism in a drug product. The Specification of sterility is unchanging and is independent of the kind of manufacturing Process. Sterilisation of the final product in its container closure system or aseptic manufacturing is followed. Under Terminal sterilisation usually it involves filling and sealing product containers under high quality Envir...
2272
537
PHARMACOGNOSTICAL EVALUATION AND ANTHELMENTIC ACTIVITY OF SWERTIA ALATA ROYLE
Objective: In the present investigation, pharmacognostical, physicochemical characteristics, thin layer chromatography and anthelmintic activity of different extracts of Swertia alata Royle were studied. Methods: Different types of preliminary and phytochemical analysis and quantitative estimation have been done along with HPTLC fingerprinting. Two concentrations (30 mg/mL and 60 mg/mL) of differe...
1228
334
CHARACTERIZATION OF ENDOGLIN GENE USING IN SILICO TOOLS
Diabetic retinopathy (DR) is a micro vascular disorder affecting the retina of the eye. Many genes have been identified for its pathogenesis. Endoglin (ENG) is one of the candidate gene involved in DR. Several literature studies helped us understand that the in vitro and in vivo studies of these candidate genes had demonstrated the role of a new gene called endoglin (ENG) capable of inhibiting ang...
1286
312
INFLUENCE OF LEVETIRACETAM ON AGGRAVATION OF MEMORY IMPAIRMENT BY VALPROATE: A STUDY ON PILOCARPINE MOUSE MODEL OF TEMPORAL LOBE EPILEPSY
Association of memory impairment (MI) with epilepsy, majorly in temporal lobe epilepsy (TLE) is considerably a tricky condition where existing treatment options involving the administration of anti-epileptic drugs (AED’s) tend to worsen the stated incidence. This study evaluates the aggravating effect of valproate (VAL) at normal and reduced doses on MI associated with TLE and additionally asses...
1392
576
IN VITRO ANTILEISHMANIAL ACTIVITY AND GC-MS ANALYSIS OF ETHYLACETATE FRACTION OF ALLIUM CEPA (EAFAC)
In this study, GC-MS analysis shown that ethyl acetate fraction of Allium cepa (EAFAC) (band one) consists of 55 compounds which shown antileishmanial activity. (IC50 73.1 ± 2.1 ug/ml) is the inhibitory concentration which is observed for ethyl acetate fraction of Allium cepa (EAFAC) (band one). Leishmania major is the specie used for this leishmanicidal assay. In this bioassay, Amphotericin B (I...
1020
298
ESTIMATION OF NELFINAVIR MESYLATE IN PHARMACEUTICAL DOSAGE FORM BY SPECTROFLUORO- PHOTOMETRY
A new specific, selective and inexpensive spectrofluorophotometric method has been developed for determination of Nelfinavir mesylate in bulk drug and its dosage form. Fluorescence spectrum of Nelfinavir mesylate in methanol showed excitation wavelength at 253 nm and emission wavelength at 508 nm. The calibration curve for Nelfinavir mesylate was found to be linear over the concentration range of ...
1368
489
QUALITY CONTROL OF PYRAZINAMIDE IN FORMULATION USING MICELLAR LIQUID CHROMATOGRAPHY
Pyrazinamide is an important anti-tubercular drug which shortens the course of TB chemotherapy. A direct injection liquid chromatographic method is developed for the determination of pyrazinamide in pharmaceutical formulation. The method includes a micellar mobile phase containing 0.15M sodium dodecyl sulphate and 1% butanol (v/v) buffered at pH3, a Princeton SPHER-100 C18 column (250mm × 4.6mm, ...
1396
401
COMPARISON OF INCIDENCE, RISK FACTORS, OUTCOME AND ANTIFUNGAL SUSCEPTIBILITY BETWEEN CANDIDA ALBICANS AND NON-ALBICANS CANDIDA SPECIES IN PATIENTS OF CANDIDEMIA IN INTENSIVE CARE SETTING
Candidemia is associated with a high mortality. The most common cause of candidemia is Candida albicans, though infections by non-albicans Candida are being increasingly reported. The present study was conducted to determine the incidence of candidemia, the risk factors and antifungal susceptibility in intensive care unit (ICU). This study was conducted from January 2012 to June 2013 and prospecti...
1069
312